Dolors Costa

5.8k total citations
73 papers, 1.2k citations indexed

About

Dolors Costa is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Dolors Costa has authored 73 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 30 papers in Genetics and 17 papers in Pathology and Forensic Medicine. Recurrent topics in Dolors Costa's work include Acute Myeloid Leukemia Research (26 papers), Chronic Lymphocytic Leukemia Research (25 papers) and Lymphoma Diagnosis and Treatment (17 papers). Dolors Costa is often cited by papers focused on Acute Myeloid Leukemia Research (26 papers), Chronic Lymphocytic Leukemia Research (25 papers) and Lymphoma Diagnosis and Treatment (17 papers). Dolors Costa collaborates with scholars based in Spain, Germany and Italy. Dolors Costa's co-authors include Ana Carrió, Dolors Colomer, Albert Fortuny, A. Borrell, Elı́as Campo, Marı́a Rozman, Neus Villamor, Jordi Esteve, Emili Montserrat and Mireia Camós and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Dolors Costa

73 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dolors Costa Spain	21	417	400	299	280	262	73	1.2k
Maya Thangavelu United States	17	307 0.7×	494 1.2×	318 1.1×	287 1.0×	239 0.9×	36	1.2k
Christiane Vermylen Belgium	20	491 1.2×	568 1.4×	237 0.8×	72 0.3×	330 1.3×	64	1.4k
Jeanette Carreras United States	15	303 0.7×	485 1.2×	95 0.3×	279 1.0×	149 0.6×	39	988
Batia Stark Israel	21	168 0.4×	653 1.6×	327 1.1×	135 0.5×	204 0.8×	66	1.3k
Andrew R. Rezvani United States	20	392 0.9×	862 2.2×	267 0.9×	361 1.3×	111 0.4×	72	1.6k
Nicolás Novitzky South Africa	20	325 0.8×	821 2.1×	180 0.6×	199 0.7×	83 0.3×	65	1.3k
Keiko Yumura‐Yagi Japan	18	155 0.4×	605 1.5×	201 0.7×	243 0.9×	150 0.6×	49	1.2k
H. Behrendt Netherlands	24	226 0.5×	419 1.0×	325 1.1×	368 1.3×	293 1.1×	74	1.5k
Maria Gilleece United Kingdom	20	405 1.0×	535 1.3×	299 1.0×	197 0.7×	46 0.2×	54	1.4k
Pascale Schneider France	14	125 0.3×	252 0.6×	394 1.3×	203 0.7×	81 0.3×	58	921

Countries citing papers authored by Dolors Costa

Since Specialization

Citations

This map shows the geographic impact of Dolors Costa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dolors Costa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dolors Costa more than expected).

Fields of papers citing papers by Dolors Costa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dolors Costa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dolors Costa. The network helps show where Dolors Costa may publish in the future.

Co-authorship network of co-authors of Dolors Costa

This figure shows the co-authorship network connecting the top 25 collaborators of Dolors Costa. A scholar is included among the top collaborators of Dolors Costa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dolors Costa. Dolors Costa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guijarro, Francesca, Irene López‐Oreja, Jordi Morata, et al.. (2024). Whole Exome Sequencing of Intermediate-Risk Acute Myeloid Leukemia without Recurrent Genetic Abnormalities Offers Deeper Insights into New Diagnostic Classifications. International Journal of Molecular Sciences. 25(16). 8669–8669. 1 indexed citations

López‐Guerra, Mònica, Álex Bataller, Francesca Guijarro, et al.. (2022). Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes. Cancers. 14(17). 4107–4107. 9 indexed citations

Ribera, Jordi, Isabel Granada, Mireia Morgades, et al.. (2021). Prognostic heterogeneity of adult B‐cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3‐PBX1 treated with measurable residual disease‐oriented protocols. British Journal of Haematology. 196(3). 670–675. 6 indexed citations

Baumann, Tycho, Riccardo Moia, Gianluca Gaïdano, et al.. (2021). Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients. Leukemia. 35(8). 2325–2331. 10 indexed citations

Rack, Katrina, Eva van den Berg, Claudia Haferlach, et al.. (2019). European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms. Leukemia. 33(8). 1851–1867. 85 indexed citations

Magnano, Laura, Olga Balagué, Iván Dlouhy, et al.. (2017). Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphoma. Annals of Oncology. 28(11). 2799–2805. 20 indexed citations

Calvo, Xavier, Meritxell Nomdedéu, Núria Martínez, et al.. (2015). Comparison of three prognostic scoring systems in a series of 146 cases of chronic myelomonocytic leukemia (CMML): MD Anderson prognostic score (MDAPS), CMML-specific prognostic scoring system (CPSS) and Mayo prognostic model. A detailed review of prognostic factors in CMML. Leukemia Research. 39(11). 1146–1153. 13 indexed citations

López, Cristina, Julio Delgado, Dolors Costa, et al.. (2012). Different distribution of NOTCH1 mutations in chronic lymphocytic leukemia with isolated trisomy 12 or associated with other chromosomal alterations. Genes Chromosomes and Cancer. 51(9). 881–889. 44 indexed citations

Nomdedéu, Meritxell, Margherita Maffioli, Xavier Calvo, et al.. (2011). Efficacy of lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2V617F mutation. Leukemia Research. 35(9). 1276–1278. 2 indexed citations

10.

González‐Porras, José Ramón, Esperanza Such, Benet Nomdedeu, et al.. (2011). The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome. Leukemia Research. 36(3). 287–292. 17 indexed citations

11.

Salaverría, Itziar, Blanca Espinet, Ana Carrió, et al.. (2008). Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques. Genes Chromosomes and Cancer. 47(12). 1086–1097. 22 indexed citations

12.

Baró, Cristina, Marta Salido, Blanca Espinet, et al.. (2007). New chromosomal alterations in a series of 23 splenic marginal zone lymphoma patients revealed by Spectral Karyotyping (SKY). Leukemia Research. 32(5). 727–736. 11 indexed citations

13.

Soler, Anna, Carmen Morales, Célia Bádenas, et al.. (2007). A Retrospective and Theoretical Evaluation of Rapid Methods for Detecting Chromosome Abnormalities and Their Implications on Genetic Counseling Based on a Series of 3868 CVS Diagnoses. Fetal Diagnosis and Therapy. 23(2). 126–131. 4 indexed citations

14.

Camós, Mireia, Jordi Esteve, Pedro Jares, et al.. (2006). Gene Expression Profiling of Acute Myeloid Leukemia with Translocation t(8;16)(p11;p13) and MYST3-CREBBP Rearrangement Reveals a Distinctive Signature with a Specific Pattern of HOX Gene Expression. Cancer Research. 66(14). 6947–6954. 91 indexed citations

15.

Madrigal, Irene, Ana Carrió, Marı́a Rozman, et al.. (2006). Fluorescence in situ hybridization studies using BAC clones of the EVI1 locus in hematological malignancies with 3q rearrangements. Cancer Genetics and Cytogenetics. 170(2). 115–120. 8 indexed citations

16.

Costa, Dolors, Blanca Espinet, Rosa Queralt, et al.. (2003). Chimeric BCR/ABL gene detected by fluorescence in situ hybridization in three new cases of Philadelphia chromosome-negative chronic myelocytic leukemia. Cancer Genetics and Cytogenetics. 141(2). 114–119. 11 indexed citations

17.

Hernández‐Boluda, Juan Carlos, Francisco Cervantes, Dolors Colomer, et al.. (2003). Genomic p16 abnormalities in the progression of chronic myeloid leukemia into blast crisis. Experimental Hematology. 31(3). 204–210. 22 indexed citations

18.

Espinet, Blanca, Françesc Solé, Francesc Bosch, et al.. (1999). Translocation (11;14)(q13;q32) and Preferential Involvement of Chromosomes 1, 2, 9, 13, and 17 in Mantle Cell Lymphoma. Cancer Genetics and Cytogenetics. 111(1). 92–98. 22 indexed citations

19.

Costa, Dolors, A. Borrell, Anna Soler, et al.. (1998). Cytogenetic Studies in Fetal Blood. Fetal Diagnosis and Therapy. 13(3). 169–175. 3 indexed citations

20.

Borrell, A., Dolors Costa, Júlia Ojuel, et al.. (1997). Limited Effectiveness of Femur and Humerus Shortening as Markers of Down Syndrome in Early Midtrimester Fetuses. Fetal Diagnosis and Therapy. 12(3). 156–162. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact